| Immune responses against SARS-CoV-2 variants after heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination J Barros-Martins, SI Hammerschmidt, A Cossmann, I Odak, MV Stankov, ... Nature medicine 27 (9), 1525-1529, 2021 | 416 | 2021 |
| Reappearance of effector T cells is associated with recovery from COVID-19 I Odak, J Barros-Martins, B Bošnjak, K Stahl, S David, O Wiesner, ... EBioMedicine 57, 2020 | 119 | 2020 |
| Single-cell transcriptomics identifies the adaptation of Scart1+ Vγ6+ T cells to skin residency as activated effector cells L Tan, I Sandrock, I Odak, Y Aizenbud, A Wilharm, J Barros-Martins, ... Cell reports 27 (12), 3657-3671. e4, 2019 | 95 | 2019 |
| Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination A Tscherne, JH Schwarz, C Rohde, A Kupke, G Kalodimou, L Limpinsel, ... Proceedings of the National Academy of Sciences 118 (28), e2026207118, 2021 | 78 | 2021 |
| A fetal wave of human type 3 effector γδ cells with restricted TCR diversity persists into adulthood L Tan, AS Fichtner, E Bruni, I Odak, I Sandrock, A Bubke, A Borchers, ... Science immunology 6 (58), eabf0125, 2021 | 62 | 2021 |
| Intranasal delivery of MVA vector vaccine induces effective pulmonary immunity against SARS-CoV-2 in rodents B Bošnjak, I Odak, J Barros-Martins, I Sandrock, SI Hammerschmidt, ... Frontiers in immunology 12, 772240, 2021 | 38 | 2021 |
| BNT162b2-boosted immune responses six months after heterologous or homologous ChAdOx1nCoV-19/BNT162b2 vaccination against COVID-19 GMN Behrens, J Barros-Martins, A Cossmann, GM Ramos, MV Stankov, ... Nature communications 13 (1), 4872, 2022 | 35 | 2022 |
| Efficient IL-2R signaling differentially affects the stability, function, and composition of the regulatory T-cell pool M Permanyer, B Bošnjak, S Glage, M Friedrichsen, S Floess, J Huehn, ... Cellular & Molecular Immunology 18 (2), 398-414, 2021 | 24 | 2021 |
| Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination J Barros-Martins, SI Hammerschmidt, A Cossmann, I Odak, MV Stankov, ... medRxiv, 2021.06. 01.21258172, 2021 | 18 | 2021 |
| Focusing of the regulatory T-cell repertoire after allogeneic stem cell transplantation indicates protection from graft-versus-host disease I Odak, S Raha, C Schultze-Florey, S Tavil, S Ravens, A Ganser, R Förster, ... haematologica 104 (12), e577, 2019 | 12 | 2019 |
| Clonal expansion of CD8+ T cells reflects graft-versus-leukemia activity and precedes durable remission following DLI CR Schultze-Florey, L Kuhlmann, S Raha, J Barros-Martins, I Odak, L Tan, ... Blood Advances 5 (21), 4485-4499, 2021 | 11 | 2021 |
| Altered and allele-specific open chromatin landscape reveals epigenetic and genetic regulators of innate immunity in COVID-19 B Zhang, Z Zhang, VACM Koeken, S Kumar, M Aillaud, HC Tsay, Z Liu, ... Cell Genomics 3 (2), 2023 | 10 | 2023 |
| Upregulation of antimicrobial peptide expression in slc26a3-/-mice with colonic dysbiosis and barrier defect A Kini, B Zhao, M Basic, U Roy, A Iljazovic, I Odak, Z Ye, B Riederer, ... Gut microbes 14 (1), 2041943, 2022 | 10 | 2022 |
| Distribution of major lymphocyte subsets and memory T-cell subpopulations in healthy adults employing GLP-conforming multicolor flow cytometry CR Schultze-Florey, E Chukhno, L Goudeva, R Blasczyk, A Ganser, ... Leukemia 35 (10), 3021-3025, 2021 | 10 | 2021 |
| Reappearance of effector T cells is associated with recovery from COVID-19. EBioMedicine 57: 102885 I Odak, J Barros-Martins, B Bošnjak, K Stahl, S David, O Wiesner, ... | 9 | 2020 |
| Longitudinal tracking of immune responses in COVID-19 convalescents reveals absence of neutralization activity against omicron and staggered impairment to other SARS-CoV-2 … I Odak, CR Schultze-Florey, SI Hammerschmidt, C Ritter, S Willenzon, ... Frontiers in immunology 13, 863039, 2022 | 8 | 2022 |
| Case report: Convalescent plasma therapy induced Anti-SARS-CoV-2 T cell expansion, NK cell maturation and virus clearance in a B cell deficient patient after CD19 CAR T cell … B Bošnjak, I Odak, C Ritter, K Stahl, T Graalmann, L Steinbrück, ... Frontiers in immunology 12, 721738, 2021 | 7 | 2021 |
| Lyz2-Cre-Mediated genetic deletion of Septin7 reveals a role of septins in macrophage cytokinesis and kras-driven tumorigenesis MB Menon, T Yakovleva, N Ronkina, A Suwandi, I Odak, S Dhamija, ... Frontiers in cell and developmental biology 9, 795798, 2022 | 5 | 2022 |
| Reappearance of effector T cells is associated with recovery from COVID-19. EBioMedicine. 2020; 57: 102885 I Odak, J Barros-Martins, B Bošnjak, K Stahl, S David, O Wiesner Epub 2020/07/11. https://doi. org/10.1016/j. ebiom. 2020.102885 PMID: 32650275, 2020 | 5 | 2020 |
| Omicron infection-associated T-and B-cell immunity in antigen-naive and triple-COVID-19-vaccinated individuals J Barros-Martins, SI Hammerschmidt, G Morillas Ramos, A Cossmann, ... Frontiers in Immunology 14, 1166589, 2023 | 3 | 2023 |
Christian Koenecke, MDHannover Medical SchoolVerified email at mh-hannover.de
